Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use – First Single-Shot Vaccine in Fight Against Global Pandemic ...Middle East

New Brunswick, NJ… Johnson & Johnson (NYSE: JNJ) (the Company) yesterday announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older. This decision was based on the totality of scientific evidence, including data from the Phase 3 ENSEMBLE study that demonstrated the vaccine was 85 percent effective in preventing severe disease across all regions studied, and showed protection against COVID-19 related hospitalization and death, beginning 28 days after vaccination. The terms of the

Read More Details
Finally We wish PressBee provided you with enough information of ( Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use – First Single-Shot Vaccine in Fight Against Global Pandemic )

Also on site :

• Russia reliable partner to Africa in strengthening sovereignty – Lavrov
• Ship carrying oil and hazardous cargo sinks off Kerala coast
• Trump’s talk on Ukraine is cheap, but the Kremlin has set him a pivotal test